Phase 2/3 clinical trial results shows early promise for an inhaled insulin spray in people with mild cognitive impairment (MCI) or mild Alzheimer’s disease.
A study published today in JAMA Neurology found that physical activity may protect against cognitive decline and the build up of amyloid beta protein, a hallmark of Alzheimer’s disease.
New research presented today (Tuesday 16th July) at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles identified a number of differences in the progression and risk of Alzheimer’s disease between women and men.
New research presented today (Tuesday 16th July) at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles identified a number of differences in the progression and risk of Alzheimer’s disease between women and men.